Dr. Steffen Thirstrup, MD, PhD, has been Chief Medical Officer at the European Medicines Agency (EMA) since June 2022. A specialist in clinical pharmacology, he has held leadership roles at the Danish Medicines Agency, served as a CHMP member at EMA, and co-chaired the European Commission’s biosimilar market access group. An adjunct professor at the University of Copenhagen, Dr. Thirstrup has authored over 40 publications and co-edited a key Danish pharmacology textbook. He divides his time between Amsterdam and Værløse, Denmark.

Dr. Peter Bachmann is a senior regulatory scientist with over 25 years of leadership at the Federal Institute for Drugs and Medical Devices (BfArM) in Germany and deep expertise in EU and global regulatory harmonization. He served as Chair of CMDh, Member of the EMA Scientific Coordination Board, EU Network Data Board, and HMA, representing the EU in ICH and as Chair of IPRP. Currently a Board Member of DGRA, he holds a Ph.D. in Pharmaceutical Biology from the University of Würzburg and completed postdoctoral research in Japan and the UK. He lectures at the Universities of Bonn, Basel, and Copenhagen, and has received TOPRA Lifetime Membership, MEGRA Honorable Membership, DIA Fellowship, and the DIA Outstanding Contribution to Health Award